Literature DB >> 22410587

Trends and challenges in tuberculosis in a medium-sized southern European setting.

M B Pasticci1, R Mazzolla, A Mercuri, G Gamboni, J C Bombaci, C Tiecco, M Rubeca, R Papili, F Pasticci, L Casali, G Ferrara, F Baldelli.   

Abstract

Trends in tuberculosis (TB) admissions over 40 years at the Infectious Diseases Clinic of Perugia University Hospital, Perugia, Italy, show that in the last decade non-Italian TB case admissions outweighed those of Italians, with a large number of cases from Eastern Europe (25.2%) and Africa (23.4%). Non-Italians tended to be younger and were generally new pulmonary TB cases, and drug resistance was also more common. Overall, the number of multidrug-resistant cases increased. Only one case occurred in a native-born Italian, and five of seven cases had newly diagnosed TB. In low TB incidence settings such as Perugia, Italy, TB prevention and control programmes for the foreign-born need to be reinforced.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22410587     DOI: 10.5588/ijtld.11.0618

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  3 in total

1.  Linezolid for drug-resistant pulmonary tuberculosis.

Authors:  Bhagteshwar Singh; Derek Cocker; Hannah Ryan; Derek J Sloan
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20

2.  Hospital admissions in Alicante (Spain): a comparative analysis of foreign citizens from high-income countries, immigrants from low-income countries, and Spanish citizens.

Authors:  José M Ramos; Eva M Navarrete-Muñoz; Hector Pinargote; Jaume Sastre; José M Seguí; María J Rugero
Journal:  BMC Health Serv Res       Date:  2013-12-09       Impact factor: 2.655

Review 3.  Risk factors for tuberculosis in foreign-born people (FBP) in Italy: a systematic review and meta-analysis.

Authors:  Loredana Ingrosso; Fenicia Vescio; Massimo Giuliani; Giovanni Battista Migliori; Lanfranco Fattorini; Santino Severoni; Giovanni Rezza
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.